AI Article Synopsis
Article Abstract
Aim: In extracerebral vascular beds cystathionine-gamma lyase (CSE) activity plays a vasodilatory role but the role of this hydrogen sulfide (H S) producing enzyme in the intracerebral arterioles remain poorly understood. We hypothesized a similar function in the intracerebral arterioles.
Methods: Intracerebral arterioles were isolated from wild type C57BL/6J mouse (9-12 months old) brains and from human brain biopsies. The function (contractility and secondary dilatation) of the intracerebral arterioles was tested ex vivo by pressure myography using a perfusion set-up. Reverse transcription polymerase chain reaction was used for detecting CSE expression.
Results: CSE is expressed in human and mouse intracerebral arterioles. CSE inhibition with L-propargylglycine (PAG) significantly dampened the K -induced vasoconstriction in intracerebral arterioles of both species (% of maximum contraction: in human control: 45.4 ± 2.7 versus PAG: 27 ± 5.2 and in mouse control: 50 ± 1.5 versus PAG: 33 ± 5.2) but did not affect the secondary dilatation. This effect of PAG was significantly reversed by the H S donor sodium hydrosulfide (NaSH) in human (PAG + NaSH: 38.8 ± 7.2) and mouse (PAG + NaSH: 41.7 ± 3.1) arterioles, respectively. The endothelial NO synthase (eNOS) inhibitor, Nω-Nitro-l-arginine methyl ester (L-NAME), and the inhibitor of soluble guanylate cyclase (sGC), 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) reversed the effect of PAG on the K -induced vasoconstriction in the mouse arterioles and attenuated the K -induced secondary dilatation significantly.
Conclusion: CSE contributes to the K -induced vasoconstriction via a mechanism involving H S, eNOS, and sGC whereas the secondary dilatation is regulated by eNOS and sGC but not by CSE.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/apha.14021 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Safety and Efficacy of Intravenous Thrombolysis by Infarct Type in Patients with No Visible Occlusion: A Secondary Analysis of the AcT Trial.
J Am Heart Assoc
December 2024
Division of Neurology, Rady Faculty of Health Sciences University of Manitoba Winnipeg MB Canada.
Background: About 25% of patients with acute ischemic stroke have lacunar infarct on follow-up imaging. In this secondary analysis from the AcT (Alteplase Compared With Tenecteplase) trial, we assessed if there is variation in safety or efficacy of intravenous thrombolysis by infarct type in patients with no visible occlusion. We also determined if this effect differed between tenecteplase and alteplase.
View Article and Find Full Text PDFInhibition of matrix metalloproteinases to reduce blood brain barrier disruption and haemorrhagic transformation in ischaemic stroke: Go broad or go narrow?
Neuropharmacology
January 2025
School of Pharmacy and Bioengineering, Keele University, Staffordshire, ST5 5BG, UK. Electronic address:
Article Synopsis
- Ischaemic stroke is caused by blockage of small arteries in the brain, leading to brain tissue damage, cognitive problems, and sometimes permanent injury.
- Current treatments like thrombolysis and thrombectomy can worsen the risk of hemorrhage due to damage to blood vessels, with matrix metalloproteinases (MMPs) playing a key role in this process.
- Inhibiting MMPs shows promise in reducing brain damage and improving outcomes in stroke patients, but there are challenges regarding how and when to use these inhibitors effectively, and they are not yet an approved therapy.
Clinical Reasoning: A 50-Year-Old Man With Intracerebral Hemorrhage and Tortuous Retinal Arterioles.
Neurology
September 2024
From the Departments of Neurology (J.B., S.W., M.L., A.N.), Genetics (S.W.), and Ophthalmology (M-A. L.), Université Caen-Normandie, CHU de Caen-Normandie, Caen; NeuroDiderot (T.C.), Université Paris Cité, Inserm UMR 1141; and Service de Génétique Moléculaire Neurovasculaire (T.C.), AP-HP, Hôpital Saint-Louis, Paris, France.
A 50-year-old man presented with headache. Examination showed left sided ataxic hemiparesis and elevated blood pressure. Brain imaging revealed an acute intracerebral hemorrhage in the right lentiform nucleus, deep and periventricular white matter hyperintensities, and predominantly deep cerebral microbleeds.
View Article and Find Full Text PDFBackground: Cerebral amyloid angiopathy (CAA) is a cerebral small vessel disease in which amyloid-β accumulates in vessel walls. CAA is a leading cause of symptomatic lobar intracerebral hemorrhage and an important contributor to age-related cognitive decline. Recent work has suggested that vascular dysfunction may precede symptomatic stages of CAA, and that spontaneous slow oscillations in arteriolar diameter (termed vasomotion), important for amyloid-β clearance, may be impaired in CAA.
View Article and Find Full Text PDFArteriolar degeneration and stiffness in cerebral amyloid angiopathy are linked to β-amyloid deposition and lysyl oxidase.
bioRxiv
April 2024
Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
Cerebral amyloid angiopathy (CAA) is a vasculopathy characterized by vascular β-amyloid (Aβ) deposition on cerebral blood vessels. CAA is closely linked to Alzheimer's disease (AD) and intracerebral hemorrhage. CAA is associated with the loss of autoregulation in the brain, vascular rupture, and cognitive decline.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!